Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy

被引：3
|
作者：
Park, JH
Park, JH
Yang, CW
Kim, YS
Kim, SY
Moon, IS
Koh, YB
Bang, BK
机构：
[1] Catholic Univ Korea, Kangnam St Marys Hosp, Dept Internal Med, Seocho Ku, Seoul 137040, South Korea
[2] Catholic Univ Korea, Kangnam St Marys Hosp, Dept Surg, Seocho Ku, Seoul 137040, South Korea
来源：
TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 07期
关键词：
D O I：
10.1016/S0041-1345(00)01393-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：1747 / 1747
页数：1
相关论文
共 50 条
  • [31] A randomized trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathy
    Metcalfe, MS
    Jain, S
    Waller, JR
    Saunders, RN
    Bicknell, GR
    Nicholson, ML
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1812 - 1814
  • [32] Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil
    Merville, P
    Bergé, F
    Deminière, C
    Morel, D
    Chong, G
    Durand, D
    Rostaing, L
    Mourad, G
    Potaux, L
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (11) : 1769 - 1775
  • [33] A randomised trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathy
    Brook, NR
    Metcalfe, MS
    Jain, S
    Bicknell, GR
    Nicholson, ML
    BRITISH JOURNAL OF SURGERY, 2003, 90 : 22 - 22
  • [34] Chronic allograft nephropathy: Effect of cyclosporine reduction and addition of mycophenolate on progression of renal disease.
    Weir, MR
    Fink, JC
    Hanes, DS
    Traver, M
    Young, C
    Schofield, K
    Blahut, S
    Klassen, DK
    Cangro, CB
    Schweitzer, E
    Bartlett, ST
    TRANSPLANTATION, 1999, 67 (07) : S82 - S82
  • [35] Mycophenolate mofetil and reduction in cyclosporine dosage for chronic renal allograft dysfunction
    Islam, MS
    Francos, GC
    Dunn, SR
    Burke, JF
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2230 - 2231
  • [36] Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function
    Fritsche, L
    Sperschneider, H
    Budde, K
    Giessing, M
    Türk, H
    Böhler, T
    Schröder, K
    Stein, G
    Neumayer, HH
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2229 - 2229
  • [37] Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection
    Kato, T
    Ruiz, P
    DeFaria, W
    Weppler, D
    Khan, F
    Pinna, A
    Nery, J
    Tzakis, A
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 396 - 396
  • [38] Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus
    Daly, I
    Jain, A
    Reyes, J
    Fung, J
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1503 - 1503
  • [39] Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression
    Lezaic, VD
    Marinkovic, J
    Ristic, S
    Dokic, ZM
    Jovanovic, GB
    Radivojevic, DM
    Blagojevic, RN
    Djukanovic, LD
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 734 - 736
  • [40] Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression
    Kim, Su-Mi
    Lee, Sang-Ho
    Lee, Arah
    Kim, Dong-Jin
    Kim, Yang-Gyun
    Kim, Se-Yun
    jeong, Kyung-Hwan
    Lee, Tae-Won
    Ihm, Chun-Gyoo
    Lim, Sung-Jig
    Moon, Ju-Young
    TRANSLATIONAL RESEARCH, 2015, 166 (04) : 375 - 383
12345